Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Actinium Pharmaceuticals Inc ATNM

Healthcare Biotechnology
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A... see more

Recent & Breaking News (NYSEAM:ATNM)

Actinium Pharmaceuticals to Present at the 23rd Annual BioCentury Future Leaders in the Biotech Industry Conference

Marketwired March 11, 2016

Actinium Pharmaceuticals Announces Filing of Provisional Patent Application Related to Commercial Scale Labeling and Processes for Iomab-B

Marketwired March 8, 2016

Actinium Pharmaceuticals to Present at the Cowen and Company 36th Annual Healthcare Conference

Marketwired March 8, 2016

Actinium Pharmaceuticals to Present at the 23rd Annual BioCentury Future Leaders in the Biotech Industry Conference

Marketwired March 3, 2016

Actinium Pharmaceuticals Selects Medpace Inc. as Clinical Research Organization for Pivotal Phase 3 Iomab-B Trial

Marketwired March 2, 2016

Actinium Pharmaceuticals to Present at the 28th Annual ROTH Conference

Marketwired February 26, 2016

Actinium Pharmaceuticals to Present at the Cowen and Company 36th Annual Healthcare Conference

Marketwired February 23, 2016

Actinium Pharmaceuticals Announces Participation at Center for International Blood & Marrow Transplant Research (CIBMTR) and American Society of Blood and Marrow Transplantation (ASBMT), February 18 - 22, 2016

Press Releases February 16, 2016

Actinium to Present at the 18th Annual BIO CEO & Investor Conference

Marketwired February 8, 2016

Actinium Pharmaceuticals Announces Participation at Upcoming Annual Meeting of Pre-Eminent Blood and Marrow Transplant Organization

Marketwired February 2, 2016

Actinium Pharmaceuticals Announces New Hires to Product Development and Clinical Research Teams

Marketwired January 26, 2016

Actinium to Present at the 18th Annual BIO CEO & Investor Conference

Marketwired January 20, 2016

Actinium Pharmaceuticals to Present at Biotech Showcase 2016

Marketwired January 11, 2016

Actinium Pharmaceuticals to Present at Biotech Showcase 2016

Marketwired January 5, 2016

Actinium to Ring First Closing Bell of 2016 at the New York Stock Exchange

Marketwired December 28, 2015

Actinium and Memorial Sloan Kettering Cancer Center Sign Agreement in Respect of Certain Liquidity Matters

Marketwired December 24, 2015

Factors Moving Markets - Research Reports on UTStarcom Holdings, Rocket Fuel, American Midstream Partners and Actinium Pharmaceuticals

Accesswire December 22, 2015

Actinium Announces Iomab-B IND Has Been Cleared By FDA; Pivotal, Phase 3 Trial to Proceed

Marketwired December 17, 2015

Clinical Trial Results for Actimab-A Presented at the 57th American Society of Hematology Annual Meeting

Marketwired December 8, 2015

Actinium Issues Letter to Shareholders Outlining Recent and Expected Milestones

Marketwired November 25, 2015